Novel Insights into Actions of Bisphosphonates on Bone: Differences in Interactions with Hydroxyapatite

Nancollas, G.H., Tang, R., Phipps, R.J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R.G.G. +1 more·2006·Bone
DOI 10.1016/j.bone.2005.05.003

Cited by (865)

Items 801–865 of 865

  1. Atypical Femoral Fractures Following Use of Intravenous Zoledronic Acid After Prior Treatment with Alendronate: A Clinical Practice Series and Opinion
    William Banks Hinshaw, Jennifer P. Schneider · 2017 · International Journal of Medical and Pharmaceutical Case Reports
  2. Impact of Bisphosphonate Bone Burden on Orthodontic Tooth Movement
    Neelambar R. Kaipatur · 2015 · ERA: Education and Research Archive (University of Alberta)
  3. Managing Osteoporosis: Real Life Issues
    Naushira Pandya · 2018 · NSUWorks (Nova Southeastern University)
  4. Healing Processes in Cancellous Bone
    Magnus Bernhardsson · 2018 · Linköping University medical dissertations
  5. Investigation of one bisphosphonate introduced on the structure and the dissolution of bioglass by using NMR and ICP-OES methods
    Bùi Xuân Vương · 2018 · VNU Journal of Science Natural Sciences and Technology
  6. Estudo pré-clínico do efeito dos bisfosfonatos na movimentação ortodôntica. Revisão sistemática da literatura
    Carlos Sanches Vargas, Rômulo Augusto Da Costa Chaves, Nádia Lunardi, Eloísa Marcantônio Boeck, Ana Paula de Souza Faloni, Guilherme José Pimentel Lopes de Oliveira · 2019 · Revista Brasileira Multidisciplinar
  7. Effect of alendronate on healing of extraction sockets and osseointegration of implants in the maxilla of rats : histologic analysis
    Jee‐Hwan Kim · 2011
  8. Osteoporose: Dauertherapie versus Therapiepause – Wofür gibt es Evidenz?
    Parvis Farahmand, J. Cassens · 2019 · Zeitschrift für Rheumatologie
  9. Concepts, perspectives and implications of a hybrid system made of nucleic acids biopolymers and hydroxyapatite mineral
    Pau Turón · 2019
  10. Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
    Yong Ho Cho, Kyung Hyun Bae, Dong Ryul Lee, Jungun Lee · 2020 · Korean Journal of Family Medicine
  11. In silico Pharmacological Screening of Nitrogen containing Bisphosphonate Conjugate with Hydroxyapatite Active Constituents in Finding Potent Inhibitors for Bone Related Diseases
    A. Kalyani · 2020 · International Journal of Bone and Rheumatology Research
  12. Synthesis of partial bisphosphonate esters with single side chain
    Alexandеr A. Kondrasenko · 2012 · UEF eRepo (University of Eastern Finland)
  13. Hydroxyapatite-based materials for smart antitumor drug delivery systems, endocytic pathways and endosomal trafficking : polymers and biopolymers
    Manuel Rivas · 2019
  14. Biochemical Alterations Accompanied to Zoledronic Acid Treatment after High Doses of Vitamin D in Experimental Model
    Abdel Maksoud H.A, Mohamed Gamal Elharrif, Anwar K. R, Abdullah M. H, Nemer Alotaibi · 2020 · Current Research in Nutrition and Food Science Journal
  15. Biomaterial approaches for the treatment and prevention of orthopaedic infections
    Stijn G. Rotman · 2020
  16. 18F-labeled Bisphosphonate as an Alternative Candidate to the Gold Standard[18F]sodium fluoride ([18F]NaF) for PET Bone Imaging
    Hishar Hassan, Muhamad Faiz Othman, Hairil Rashmizal Abdul Razak · 2021 · Current Medical Imaging Formerly Current Medical Imaging Reviews
  17. Bisfosfonatos: Os Compostos Multivalentes da Indústria Farmacêutica
    Filipe A. Almeida Paz, Jéssica S. Barbosa, Susana Santos Braga · 2020 · Boletim da Sociedade Portuguesa de Química
  18. Diffuse Damage Repair Mechanism in Bone
    Leila Mehraban Alvandi · 2020 · CUNY Academic Works (City University of New York)
  19. Functional small-molecule probes for fluorescence imaging of osteoclasts in vivo
    Toshiyuki Kowada · 2021
  20. Treatment of Paget's disease of the bone: long-term effect of neridronate in a real-life setting
    Fiammetta ROMANO, Elea DI BENEDETTO, Elisabetta SCARANO, Enrico RICCIO, Rossana ARIANNA, Annamaria COLAO, Carolina Di Somma · 2022 · Minerva Endocrinology
  21. Current World Literature
    2007 · Current Opinion in Endocrinology Diabetes and Obesity
  22. Osteonecrosis
    Caterina Musolino, Alessandro Allegra · 2012 · Springer eBooks
  23. Literature Survey
    2007 · Springer eBooks
  24. The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood γδ T cells for the treatment of bone cancer metastasis
    Shirin Kalyan, Wei He, Dieter Kabelitz · 2014 · Elsevier eBooks
  25. Biomarkers in Bone Metastases
    Bülent Karabulut · 2021 · Turkish Journal of Oncology
  26. Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – ECCEO 9 – IOF
    Johannes P.T.M. van Leeuwen, van Driel, M., Eijken, M. · 2009 · Osteoporosis International
  27. Implicaciones de la utilización de las guías de mayor impacto internacional (NOGG y NOF) como de otras guías (internacionales, nacionales y locales) en la eficiencia diagnóstica y terapéutica de la osteoporosis en el Área de Salud de León = Implications of the use of the guidelines with the greater international impact (NOGG and NOF) and other guidelines (international, national and local) on the diagnostic and therapeutic efficiency of osteoporosis in the health area of León
    Georgios Kyriakos · 2016
  28. Clinical efficacy of bisphosphonates and monoclonal antibodies on bone mineral density following skeletal fractures
    Priya Sharma, Oday Al‐Dadah · 2022 · Journal of Clinical Orthopaedics and Trauma
  29. Avaliação dos fatores de risco para o desenvolvimento de osteonecrose dos maxilares induzida por bisfosfonatos (ONMB) em pacientes oncológicos usuários de bisfosfonato intravenoso
    Victor Augusto Minari · 2022
  30. Risikofaktoren und Therapie von Antiresorptiva-assoziierten Kiefernekrosen, eine retrospektive Analyse an der Universitätsmedizin Göttingen
    Johanna Liesa Gollasch · 2023
  31. Einfluss von Zoledronat und Denosumab auf humane Zellen der osteoblastären Linie aus dem Kieferknochen anhand osteogener Marker
    Lautenbacher, Florian · 2023
  32. Desarrollo de un inyectable liofilizado de ácido zoledrónico 5 mg. Estudio de estabilidad
    Yenilen Troche Concepción, Nancy Burguet Lago, Alen N. Baeza-Fonte, Griset Toledo-Carrabeo, Mirna Fernández Cervera, YunetMirka Herrera-Espino · 2022 · Revista Colombiana de Ciencias Químico Farmacéuticas
  33. Vitamin D and Paget's disease
    Noriyoshi Kurihara, G. David Roodman · 2023 · Elsevier eBooks
  34. The effects of zoledronic acid treatment and endurance exercise on ovariectomy-induced osteopenia in Wistar rats
    Hsin-Shih Lin, Rong‐Sen Yang, Jack L. Lewis, Ming‐Shi Chang, Ar‐Tyan Hsu, Tsang‐Hai Huang · 2024 · Sport Sciences for Health
  35. Risk factors for medication-related osteonecrosis of the jaws in menopausal women
    Jocarla Campos Serafim, Gustavo Azevedo Pitol, Ester Victorino Coser, Ben‐Hur Albergaria, Stefânia Carvalho Kanô, Tânia Regina Grão Velloso · 2024 · Brazilian journal of oral sciences/Brazilian Journal of Oral Sciences
  36. Interaction from Structure-Activity Relation Perspective
    Bárbara Gonçalves Rivello, Jhon Kennedy Alves Pereira, Igor Victor Ferreira dos Santos, Cleydson B. R. Santos, James Oluwagbamigbe Fajemiroye, Ricardo Menegatti · 2025 · Springer eBooks
  37. Synthesis and Biological Evaluation of 131I-Risedronate with Bone Targeting Activity
    Zehui Lin, Wangxi Hai, Pengfei Pan, Jin‐Hong Lin, Biao Li, Ji‐Chang Xiao · 2025 · Molecular Pharmaceutics
  38. Fabrication and evaluation of the zoledronic acid loaded cationic starch-hydroxyapatite-ZrO2 nanocomposites for bone disease treatment
    Kiseok Han, Anbazhagan Sathiyaseelan, Batthula Srinivas, Myeong-HyeonWang · 2025 · Journal of Molecular Liquids
  39. The effects of geranylgeranyl diphosphate synthase inhibitor treatment on osteoblast biology and application in a conditioned media model of myeloma bone disease
    Molly E. Muehlebach, Sarah A. Holstein · 2025 · Bone Reports
  40. Synthesis of functionalized hydroxymethyl-substituted organophosphorus acids
    Yu. N. Bubnov, Andrey A. Prishchenko, Michail V. Livantsov, O. P. Novikova, Ludmila I. Livantsova, S. V. Baranin · 2025 · Russian Chemical Bulletin
  41. Tannic Acid and Pamidronate Synergistically Modulate Osteoblast and Osteoclast Activity in a Human Co-Culture Model
    Nurul Husna Azizul, Hermizi Hapidin, Hasmah Abdullah, Maryam Azlan, Azlina Ahmad, Soelaiman Ima-Nirwana · 2025 · Bratislavské lekárske listy/Bratislava medical journal
  42. Osteoporosis Drugs: Old and New Drugs
    Boselli Federica, Maria Grazia Radaelli · 2025 · Springer eBooks
  43. Calcium silicate in drug delivery
    Vinod L. Gaikwad, Pratik R. Dhake, Vaibhav S. Mahalinge · 2025 · Elsevier eBooks
  44. The use of bisphosphonates and statins in cancer treatment in dogs: New therapeutic approaches
    Fatma Cinbat, Fulya Üstün Alkan · 2025 · Journal of Istanbul Veterinary Sciences
  45. Deciphering the spatial and microstructural landscape in subchondral bone remodeling of temporomandibular joint osteoarthritis
    Meng-Nan Cao, Shi-Yang Feng, Yi-Xin Li, Chen-Chen Gao, Kai‐Yuan Fu, Jie Lei · 2026 · Materials & Design
  46. Bone Healing After Tooth Extraction in a Patient on Oral Bisphosphonates: A Case Report
    Antonello Falco, Lorenzo Vittorini Orgeas, Roberta Di Pietro, Loredana Masciotra, Sergio Rexhep Tari, Calogero Bugea, Antônio Scarano · 2026 · Osteology
  47. İlaçlara Bağlı Çene Kemiği Osteonekrozu: Etken İlaç Grupları, Tanı ve Tedaviye Dair Görüşler ve Kavramlar
    Elif Aslan · 2026 · Akdeniz Medical Journal
  48. Étude de l’effet des bisphosphonates sur l’activité anti-tumorale des lymphocytes T Vγ9Vδ2 humains
    Ismahène Benzaïd · 2009
  49. Multifunctional PBLG nanoparticles for bone targeting and anticancer drug delivery into bone tissues
    Laura De Miguel Martínez de Aragón · 2013
  50. Scandium complexes : physico-chemical study and evaluation of stability in vitro and in vivo for nuclear medicine application
    R. Kerdjoudj · 2014
  51. Nanoparticules en environnement cellulaire : Impact de la nano-architecture sur l'internalisation, la biodégradation et les fonctionnalités thérapeutiques.
    Anouchka Plan Sangnier · 2019
  52. Bisphosphonate use and pregnancy complications: Insights from the FDA adverse event reporting system (FAERS) database
    Nur Yazdalı Köylü, Buğra Han Esen, Ümmü Mutlu, Hülya Hacışahinoğulları, Gülşah Yenidünya Yalın, Ayşe Kubat Üzüm · 2026 · Bone
  53. In situ MALDI mass spectrometry imaging of pharmaceuticals and metabolites in human teeth and jawbone
    Hameda Amin, Marcus Daniel Brandbjerg Bohn Lorensen, Harald Severin Hansen, Azam Bakhshandeh, Thomas Kofod, Sanne Werner Moeller Andersen, Camilla Kragelund, Christian Janfelt · 2026 · Analytical and Bioanalytical Chemistry
  54. Adjuvants Alter the Setting Behavior of a Ceramic Bone Graft Substitute: Implications for the Laboratory and Operating Room
    Felix Lamadé-Dootz, Nick Mattern, Sanja Kalmus, Alma Aubert, Paul Alfred Grützner, Jonas Armbruster, Holger Freischmidt · 2026 · Materials
  55. Acido zoledronico: trattamento e prevenzione dell’osteoporosi
    Salvatore Minisola · 2026 · L Endocrinologo
  56. Alkoxy- and dialkylaminomethylation of methylene bisorganophosphorus acid derivatives
    Yu. N. Bubnov, A. A. Prishchenko, S. V. Baranin · 2026 · Russian Chemical Bulletin
  57. Chitosan-coated zeolites as a promising platform for sodium risedronate adsorption
    Jakub Matusiak, Rafał Panek, Paulina Kazimierczak, Alicja Wójcik, Hossein Kazemian, Agata Przekora, Wοjciech Franus · 2026 · Materials & Design
  58. Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum
    MASSIMO VARENNA, Chiara Crotti, Raffaele Di Taranto, Francesco Orsini, Francesca Zucchi · 2026 · Expert Review of Clinical Pharmacology
  59. Interface Control of Poly(L-lactic Acid)/Hydroxyapatite Composites by Using Bisphosphonate
    Rin Ito, Rumi Nishimura, Mamoru Aizawa, Masahiro Yoshizawa‐Fujita, Masahiro Rikukawa, Yuko Takeoka · 2026 · ACS Omega
  60. Impact of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk: real-world evidence from a retrospective cohort study
    张树泉, Zhixiang Wang, Ruotong Zhou, Wei Yu, Qianqian Pang, Ruizhi Jiajue, Lijia Cui, Wei Liu, Yan Jiang, Mei Li et al. · 2026 · Osteoporosis International
  61. BindingDB Entry 50022697: An insight into recent developments in imidazole based heterocyclic compounds as anticancer agents: Synthesis, SARs, and mechanism of actions.
    BindingDB · 2026 · UC San Diego
  62. BindingDB Entry 50031565: Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).
    BindingDB · 2010 · UC San Diego
  63. BindingDB Entry 50039150: Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.
    BindingDB · 2012 · UC San Diego
  64. BindingDB Entry 50017358: Bisphosphonates, Old Friends of Bones and New Trends in Clinics.
    BindingDB · 2023 · UC San Diego
  65. The isoprenoid biosynthesis pathway and regulation of osteoblast differentiation
    Megan Moore Weivoda · 2011